Grato Holdings, Inc. – FDA 483, Jul 14, 2021
An FDA inspection of Grato Holdings, Inc. in Woodbine, IA, revealed significant deficiencies across multiple areas of their drug manufacturing operations. The firm failed to properly calibrate laboratory equipment, conduct thorough investigations into product discrepancies, and maintain adequate computer system security for analytical data. Additionally, issues were noted with microbiological media testing and the cleaning and sanitization of raw material sampling utensils, indicating a broad lack of adherence to good manufacturing practices.
ID · 18dd63bd-16c4-4cec-9760-4f6cbed3357c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.